Apolipoprotein E Drives Early Blood–Brain Barrier Damage in Alzheimer’s Disease

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Iadecola C. Dangerous Leaks: Blood–brain barrier woes in the aging hippocampus. Neuron 2015, 85: 231–233.

    Article  CAS  Google Scholar 

  2. 2.

    Yang Q, Chen K, Zhang H, Zhang W, Gong C, Zhang Q, et al. Correlations between single nucleotide polymorphisms, cognitive dysfunction, and postmortem brain pathology in Alzheimer’s disease among Han Chinese. Neurosci Bull 2019, 35: 193–204.

    Article  CAS  Google Scholar 

  3. 3.

    Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline. Nature 2020, 581: 71–76.

    Article  CAS  Google Scholar 

  4. 4.

    Montagne A, Zhao Z, Zlokovic BV. Alzheimer’s disease: A matter of blood–brain barrier dysfunction? J Exp Med 2017, 214: 3151–3169.

    Article  CAS  Google Scholar 

  5. 5.

    Nation DA, Sweeney MD, Montagne A, Sagare AP, D’Orazio LM, Pachicano M, et al. Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 2019, 25: 270–276.

    Article  CAS  Google Scholar 

  6. 6.

    Santos G, Magno L, Romano-Silva MA, Mintz A, Birbrair A. Pericyte plasticity in the brain. Neurosci Bull 2019, 35: 551–560.

    Article  Google Scholar 

  7. 7.

    Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012, 485: 512–516.

    Article  CAS  Google Scholar 

  8. 8.

    Halliday MR, Rege SV, Ma Q, Zhao Z, Miller CA, Winkler EA, et al. Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease. J Cereb Blood Flow Metab 2016, 36: 216–227.

    Article  CAS  Google Scholar 

  9. 9.

    Miners JS, Schulz I, Love S. Differing associations between Abeta accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer’s disease. J Cereb Blood Flow Metab 2018, 38: 103–115.

    Article  CAS  Google Scholar 

  10. 10.

    Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood–brain barrier breakdown in the aging human hippocampus. Neuron 2015, 85: 296–302.

    Article  CAS  Google Scholar 

  11. 11.

    Fan D, Wang Y. Early intervention in Alzheimer’s disease: How early is early enough? Neurosci Bull 2020, 36: 195–197.

    Article  CAS  Google Scholar 

  12. 12.

    Sun B, Li W, Zhu C, Jin W, Zeng F, Liu Y, et al. Clinical research on Alzheimer’s disease: Progress and perspectives. Neurosci Bull 2018, 34: 1111–1118.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This research highlight was supported by the National Key Projects for Research and Development Program of China (2016YFC1305800 and 2016YFC1305802); the National Natural Science Foundation of China (81671256 and 81871069); the Key Project for Research and Development Program of Jiangsu Province (BE2018741), and the Nanjing International Joint Research and Development Project (201715013).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Chunming Xie.

Ethics declarations

Conflict of interest

All authors declare no competing interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, Q., Xie, C. Apolipoprotein E Drives Early Blood–Brain Barrier Damage in Alzheimer’s Disease. Neurosci. Bull. (2020). https://doi.org/10.1007/s12264-020-00596-2

Download citation